Making a difference to the people we help treat by creating value and improving healthcare outcomes through connecting innovative manufacturers with Australasian customers.

Healing Eyes with Precision: Research Empowered by Merck’s MILLIPLEX® Technology

Imagine using part of your blood to help heal your eyes

A study by Liu et al. (2025) explores a new way to treat corneal neovascularization, a condition where unwanted blood vessels grow into the eye, often causing vision loss. Instead of relying on steroids or injections, researchers used tiny particles called extracellular vesicles, which are naturally released by platelets (the part of your blood that helps stop bleeding and repair injuries). 

They loaded these vesicles with kaempferol, a plant-based compound known for its anti-inflammatory and anti-angiogenic (anti-blood vessel growth) properties. The result? A simple eye drop that reduced inflammation, blocked abnormal vessel growth, and helped the eye heal more effectively. 

Why we found this exciting: 

It’s a smart, gentle approach that uses the body’s own healing tools to deliver treatment exactly where it’s needed, without the risks of long-term steroid use or invasive procedures. 

To measure how well the treatment worked, the team used the MILLIPLEX xMAP Mouse Cytokine/Chemokine Magnetic Bead kits (Merck Millipore) which can be found in our portfolio for research solutions. This assisted the researchers in tracking inflammation and healing markers in the eye. 

Congratulations to Guei-Sheung (Rick) Liu, Huai-An Chen, Che-Yi Change, Yin-ju Chen, Yu-yi Wu, Ariel Widhibrata, Ya-Han Yang, Erh-Hsuan Hsieg, Liling Delila, I-Change Lin, Thierry Burnouf and Ching-Li Tseng

Read the full article here

Read here >

Learn more about Merck Milliplex Mouse Cytokine

Click here >

Reference: 

Liu, G.-S. et al. (2025) ‘Platelet-derived extracellular vesicle drug delivery system loaded with Kaempferol for treating corneal neovascularization’, Biomaterials, 319, p. 123205. doi:10.1016/j.biomaterials.2025.123205.

Request a Quote

Request Quote

Recent Posts

Developing Diagnostic Kits for Ovarian Cancer

In Australia, ovarian cancer is the deadliest reproductive cancer. The average five‑year survival rate sits at around 49%, compared with about 92% for breast cancer,…

Read full article

Merck FemtoQuest™

Gain your desired immunoassay sensitivity with the ultrasensitive FemtoQuest™ system Measure down to femtogram/mL levels Improved precision and robust data Perform dual-plex and single analyte…

Read full article

Vector VectaMount® Mounting Media for IHC

VectaMount Mounting Medium Products When applying a coverslip, selecting the appropriate mounting medium is essential to preserve the clarity, contrast, and stability of histochemical stains…

Read full article